Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia

Background: Anti-PD-1/PD-L1 immunotherapy has achieved impressive responses in multiple types of malignancies in recent years. However, immune-related adverse events (irAEs) occur and limit their continuous clinical use. Among these irAEs, acquired amegakaryocytic thrombocytopenia (AAT) is rare but...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Xiaofang, Xue, Ali, Wu, Suye, Jin, Mengmeng, Zhao, Pu, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830913/
https://www.ncbi.nlm.nih.gov/pubmed/35153753
http://dx.doi.org/10.3389/fphar.2021.795884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830913/
https://www.ncbi.nlm.nih.gov/pubmed/35153753
http://dx.doi.org/10.3389/fphar.2021.795884

Ejemplares similares